We knew it wouldn’t be long before the cannabis industry started taking market share from the wine and spirits industry, and here to showcase that trend is Chip Forsythe, CEO of Rebel Coast Winery.

Founded in 2013, this California winery is making a major splash with its alcohol-removed, THC-infused wine - a beverage that offers a very different kind of buzz (and skips the hangover).

In this episode, Chip shares a behind-the-scenes look at the meticulous process involved in creating cannabis wine, Rebel Coast’s plans for the future, and his insights on where the cannabis beverage market is headed in the next few years.

Learn more at https://rebelcoast.com

Key Takeaways:

• Chip’s background in wine and what led him to start Rebel Coast Winery
• How Rebel Coast’s cannabis wine compares to traditional wine in terms of taste, aroma, and calorie count
• The difficult process behind infusing wine with cannabis and how long it took Chip and his team to get it right
• Regulatory and logistical hoops Chip still has to jump through in order to keep Rebel Coast alive and kicking
• Difficulties in scaling the production of cannabis-infused wine and the ways in which Rebel Coast has worked to overcome them
• Chip’s work educating regulators and politicians so that the cannabis industry can continue to grow and become more diverse
• What’s on tap next for Rebel Coast Winery and where Chip sees the cannabis beverage market going over the next 3-5 years

With business models from other industries quickly making their way into the cannabis industry, TILT Holdings is aiming to become the swiss army knife of business-to-business offerings in the cannabis space.

A vertically-integrated infrastructure and technology platform, TILT Holdings delivers contract manufacturing, distribution, hardware, and software for over 1,500 retailers and brands throughout the U.S., Canada, and Europe.

In this episode, TILT Holdings CEO Alex Coleman shares with us an in-depth look at the goings-on at TILT, shares his insights on the future of cannabis, and provides some invaluable advice on how to navigate the cannabis B2B market.

Learn more at https://www.tiltholdings.com.

Key Takeaways:

• Alex’s background in cannabis and what inspired him to start a B2B business in the cannabis space
• A deep dive into Tilt Holdings and the various companies under its umbrella, including Baker Technologies and Sea Hunter Therapeutics
• How Alex believes the recently passed Farm Bill of 2018 will impact the cannabis industry over the coming years
• Up-and-coming technologies like AI, gene editing, and nanotechnology and their implications for cannabis
• Why big alcohol and tobacco companies are investing in cannabis and the traditional businesses Alex predicts will follow suit
• Alex’s outlook for the future of cannabis and what he believes the industry will look like in 2030

With the cannabis market projected to hit $31 billion by 2021, it’s easy to feel like the industry has simply taken on its own momentum.

However, what most people don’t know is that there’s a group of investors called The Arcview Group that funds the very companies we’ll be reading about in the headlines 1-2 years from now.

In this episode, founder and CEO of Arcview Troy Dayton gives us an in-depth look at the goings-on at Arcview, shares his insights on the future of cannabis, and provides some invaluable advice for those looking to take the plunge.

Learn more at https://arcviewgroup.com

Key Takeaways:

• The cannabis industry’s current landscape and where Troy sees it heading over the next few years
• How The Arcview Group has evolved from angel investors to now also include venture capitalists and large companies looking to make acquisitions
• Overlaps in the entertainment and cannabis industries and how this could positively influence cannabis’ growth
• The amount of capital Arcview investors have invested to date and projections for the future
• Troy’s advice on what to look for when investing in startups
• A deep dive into Arcview Ventures and Arcview Market Research
• What it will take for cannabis to become as established as other industries and start seeing more interstate commerce

Can small-scale craft cannabis survive against huge corporations and the big ad practices they’re introducing to North America?

Here to help us answer that is Ryan Stoa, Associate Professor at Concordia University School of Law and author of "Craft Weed: Family Farming and the Future of the Marijuana Industry."

In this episode, Ryan argues the need to keep cannabis “more craft beer than Anheuser-Busch” and proposes a Marijuana Appellation system that would support a sustainable, local, and artisanal farming model within the U.S.

Learn more at http://ryanstoa.com

Key Takeaways:

• Ryan’s background in law and cannabis and what sparked his desire to write “Craft Weed”
• Why Ryan argues we need to support craft weed over big companies with large scale cultivation facilities
• The extensive research that went into Ryan’s book and the information that shocked him the most
• Smart farming and how it relates to indoor cannabis growing
• How Ryan believes the newly passed Farm Bill of 2018 will affect the small American family farm
• Why the desire for sustainable, artisanal cannabis fluctuates across the U.S.
• Ryan’s positive outlook for the future of cannabis agriculture and how he believes legalization will benefit our culture

With the recent global surge in industrial hemp, scientists are moving into the hemp and cannabis space to provide cultivators the technologies and best practices of other industries.

Helping lead the movement is Dr. Jon Vaught, CEO and founder of Front Range Biosciences, an agricultural biotechnology company that specializes in tissue culture cloning for cannabis and other high-value crops.

In this episode, Dr. Jon shares how Front Range Biosciences is revolutionizing cloning methods to not only produce robust, healthy plants but also create new varieties that could disrupt the dietary and pharmaceutical industries.

Learn more at https://www.frontrangebio.com

Key Takeaways:

• A breakdown of Front Range Biosciences and the revolutionary biotechnology it’s bringing to the cannabis industry
• Dr. Jon’s background in biotechnology and what led him to start Front Range Biosciences
• The differences between cannabis and hemp
• A deep dive into Front Range Biosciences’ services, including its Clean Stock Nursery Program
• The ins and outs of tissue culture laboratories and the benefits they offer researchers and cultivators alike
• How to avoid common mistakes in cultivation, including exposing plants to disease
• Dr. Jon’s goals to create new plant varieties and cannabinoid profiles for the purposes of dietary supplements, nutraceutical products, and even pharmaceutical products
• Our current understanding of the cannabis genome and the exciting new discoveries Dr. Jon anticipates in the years to come